About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 614 record(s)
Req # A-2021-002075
Adverse Drug Reactions (ADRs). Report numbers: E2B_03242218, E2B_03790563.Organization: Health Canada
May 2022
Req # A-2021-002077
Adverse Drug Reactions (ADRs) for ROSUVASTATIN CALCIUM, POLYSTYRENE SULFONATE SODIUM. Report numbers: E2B_04926840, 000969894.Organization: Health Canada
May 2022
Req # A-2021-002085
Adverse Drug Reactions (ADRs) for ZOPICLONE. Report numbers: E2B_04794616, E2B_04821400, E2B_04821402, E2B_04766136, E2B_04820050, E2B_04766138, E2B_04819537, E2B_04771044, E2B_04821403, E2B_04821401, E2B_04772198, E2B_04819973.Organization: Health Canada
May 2022
Req # A-2021-002086
Adverse Drug Reactions (ADRs) for ZOPICLONE. Report numbers: E2B_04773900, E2B_04819538, E2B_04773927, E2B_04819530, E2B_04779830, E2B_04789762, E2B_04819802, E2B_04821412, E2B_04824930, E2B_04824938.Organization: Health Canada
May 2022
Req # A-2021-002096
Adverse Drug Reaction (ADR) for BISACODYL. Report number: E2B_04699223.Organization: Health Canada
May 2022
Req # A-2021-002100
Adverse Drug Reactions (ADRs) for METFORMIN HYDROCHLORIDE, ENOXAPARIN SODIUM. Report numbers: E2B_04787817, E2B_04666164, 000977133, 000968959.Organization: Health Canada
May 2022
Req # A-2021-002101
Adverse Drug Reaction (ADR) for BISACODYL. Report number: E2B_04949285.Organization: Health Canada
May 2022
Req # A-2021-002133
Adverse Drug Reactions (ADRs). Report numbers: 000977561, E2B_03630855.Organization: Health Canada
May 2022
Req # A-2021-002137
Adverse Drug Reaction (ADR). Report number: 000977590.Organization: Health Canada
May 2022
Req # A-2021-002149
Adverse Drug Reactions (ADRs) for BISACODYL. Report numbers: E2B_04825443, E2B_04699223, E2B_04892483, E2B_04949285.Organization: Health Canada
May 2022